CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
CDK4 磷酸化状态及 CDK4/6 和 BRAF/MEK 抑制剂联合治疗晚期甲状腺癌的合理应用
期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2023.1247542
Pita Jaime M, Raspé Eric, Coulonval Katia, Decaussin-Petrucci Myriam, Tarabichi Maxime, Dom Geneviève, Libert Frederick, Craciun Ligia, Andry Guy, Wicquart Laurence, Leteurtre Emmanuelle, Trésallet Christophe, Marlow Laura A, Copland John A, Durante Cosimo, Maenhaut Carine, Cavaco Branca M, Dumont Jacques E, Costante Giuseppe, Roger Pierre P